The detailed information for PTAB case with proceeding number IPR2024-00170 filed by Foresight Diagnostics Inc. against Personalis, Inc. on Nov 22, 2023. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2024-00170
Filing Date
Nov 22, 2023
Petitioner
Foresight Diagnostics Inc.
Respondent
Personalis, Inc.
Status
Terminated-Settled
Respondent Application Number
17494513
Respondent Tech Center
1600
Respondent Patent Number
11584968
Institution Decision Date
May 28, 2024
Termination Date
Jul 5, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Decision: Post-DI Settlement

Jul 5, 2024PAPERBOARD

Joint Motion to Terminate

Jun 28, 2024PAPERPATENT OWNER

[Confidential] Settlement Agreement

Jun 28, 2024EXHIBITPATENT OWNER

Joint Request to File Settlement Agreement

Jun 28, 2024PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Jun 28, 2024PAPERPATENT OWNER

Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314

May 28, 2024PAPERBOARD

Order: SCHEDULING ORDER

May 28, 2024PAPERBOARD

Exhibit 3002

May 28, 2024EXHIBITBOARD

Exhibit 3003

May 28, 2024EXHIBITBOARD

EX1107 First Amended Complaint [Replacement]

Apr 24, 2024EXHIBITPETITIONER

EX1108 '513 File History [Replacement]

Apr 24, 2024EXHIBITPETITIONER

Exhibit 3001

Apr 23, 2024EXHIBITBOARD

Patent Owner's Sur-Reply to Petition for Inter Partes Review

Mar 29, 2024PAPERPATENT OWNER

Petitioner's Authorized Reply to POPR

Mar 19, 2024PAPERPETITIONER

EX1127 Furneaux Decl. (from IPR2023-00224)

Mar 19, 2024EXHIBITPETITIONER

Petitioner's Updated Exhibit List

Mar 19, 2024PAPERPETITIONER

Patent Owner Preliminary Response IPR2024-00170

Feb 29, 2024PAPERPATENT OWNER

TheScientist - 2022 Top 10 Innovations

Feb 29, 2024EXHIBITPATENT OWNER

Curriculum Vitae of Henry Furneaux

Feb 29, 2024EXHIBITPATENT OWNER

2023-09-21 Deposition Transcript of John Quackenbush

Feb 29, 2024EXHIBITPATENT OWNER

Institution Decision in the related matter of Foresight Diagnostics Inc. v. Personalis, Inc., IPR2023-00224, Paper 11

Feb 29, 2024EXHIBITPATENT OWNER

Low-coverage Whole Genome Sequencing

Feb 29, 2024EXHIBITPATENT OWNER

Nguyen et al., Automation of molecular-based analyses a primer on massively parallel sequencing

Feb 29, 2024EXHIBITPATENT OWNER

Jessri et al., Harnessing massively parallel sequencing in personalized head and neck oncology

Feb 29, 2024EXHIBITPATENT OWNER

Forshew, et al., EX1030 in IPR2023-00224

Feb 29, 2024EXHIBITPATENT OWNER

Zvaifler et al., Mesenchymal precursor cells in the blood of normal individuals

Feb 29, 2024EXHIBITPATENT OWNER

Solovey et al.,Circulating activated endothelial cells in sickle cell anemia

Feb 29, 2024EXHIBITPATENT OWNER

Schmid et al., Circulating Endothelial Progenitor Cells,

Feb 29, 2024EXHIBITPATENT OWNER

Efrati et al., The morphology of buffy coat in normal human adults

Feb 29, 2024EXHIBITPATENT OWNER

Declaration of Dr. Henry Morrice Furneaux

Feb 29, 2024EXHIBITPATENT OWNER

Spiro et al

Feb 29, 2024EXHIBITPATENT OWNER

Foresight’s (CORRECTED) Reply to Patent Owner’s Response

Feb 29, 2024EXHIBITPATENT OWNER

Notice : Mandatory Notice

Dec 13, 2023PAPERPATENT OWNER

Notice : Power of Attorney

Dec 13, 2023PAPERPATENT OWNER

Notice: Notice filing date accorded

Nov 30, 2023PAPERBOARD

Petition : as filed

Nov 22, 2023PAPERPETITIONER

Notice : Power of Attorney

Nov 22, 2023PAPERPETITIONER

EX1001 West US11,584,968

Nov 22, 2023EXHIBITPETITIONER

EX1002 Leary, Dev of Personalized Tumor Biomarkers

Nov 22, 2023EXHIBITPETITIONER

EX1003 Quake WO 2011-057061

Nov 22, 2023EXHIBITPETITIONER

EX1005 Gnirke Solution hybrid selection with ultra-long oligonucleotides

Nov 22, 2023EXHIBITPETITIONER

EX1006 Mertes, Targeted enrichment of Genomic DNA regions

Nov 22, 2023EXHIBITPETITIONER

EX1007 Mamanova, Target-enrichment strategies

Nov 22, 2023EXHIBITPETITIONER

EX1008 Chan, Cancer Genome Scanning in Plasma

Nov 22, 2023EXHIBITPETITIONER

EX1010 First Amended Complaint (22-01913)

Nov 22, 2023EXHIBITPETITIONER

EX1012 Ley, DNA sequencing of a cytogenetically normal acute....

Nov 22, 2023EXHIBITPETITIONER

EX1013 Shendure, Next-generation DNA sequencing

Nov 22, 2023EXHIBITPETITIONER

EX1014 Ross, Whole Cancer Genome Sequencing

Nov 22, 2023EXHIBITPETITIONER

EX1015 McBride, Use of Cancer-Specific Genomic Rearrangements

Nov 22, 2023EXHIBITPETITIONER

EX1021 Hsieh-Yee Declaration

Nov 22, 2023EXHIBITPETITIONER

EX1023 Quackenbush CV

Nov 22, 2023EXHIBITPETITIONER

EX1024 Types of variants, Garvan Institute of Medical Research

Nov 22, 2023EXHIBITPETITIONER

EX1027 Lam, Performance comparison

Nov 22, 2023EXHIBITPETITIONER

EX1028 Technote coverage calculation

Nov 22, 2023EXHIBITPETITIONER

EX1029 Illumina, HiSeq 2000 Sequencing System

Nov 22, 2023EXHIBITPETITIONER

EX1031 Meyerson, Advances in understanding cancer genomes

Nov 22, 2023EXHIBITPETITIONER

EX1037 Infringement Claim Chart-Ex. O of FAC

Nov 22, 2023EXHIBITPETITIONER

EX1040 Sims, Sequencing depth and coverage

Nov 22, 2023EXHIBITPETITIONER

EX1042 Ley Suppl. Info

Nov 22, 2023EXHIBITPETITIONER

EX1043 Newman

Nov 22, 2023EXHIBITPETITIONER

EX1044 Newman 2014

Nov 22, 2023EXHIBITPETITIONER

EX1070 Dawson, Analysis of Circulating Tumor DNA

Nov 22, 2023EXHIBITPETITIONER

EX1077 Bentley, Accurate whole human genome sequencing

Nov 22, 2023EXHIBITPETITIONER

EX1100 Declaration of John Quackenbush Ph.D.

Nov 22, 2023EXHIBITPETITIONER

EX1101 Okosun I

Nov 22, 2023EXHIBITPETITIONER

EX1102 Okosun II

Nov 22, 2023EXHIBITPETITIONER

EX1103 Chapman 2011

Nov 22, 2023EXHIBITPETITIONER

EX1104 Lee 2010

Nov 22, 2023EXHIBITPETITIONER

EX1105 Ding 2010

Nov 22, 2023EXHIBITPETITIONER

EX1106 Guan, Application of next-generation sequencing

Nov 22, 2023EXHIBITPETITIONER

EX1107 First Amended Complaint #021 (23-01623)

Nov 22, 2023EXHIBITPETITIONER

EX1108 '513 FH

Nov 22, 2023EXHIBITPETITIONER

EX1109 Qiagen Protocol

Nov 22, 2023EXHIBITPETITIONER

EX1110 Spec Sheet Access Array System

Nov 22, 2023EXHIBITPETITIONER

EX1111 Hohaus,Cell-free circulating DNA

Nov 22, 2023EXHIBITPETITIONER

EX1112 Diehn US2022-0195530

Nov 22, 2023EXHIBITPETITIONER

EX1113 Supplementary Info

Nov 22, 2023EXHIBITPETITIONER

EX1114 EX2031 Furneaux Dec from IPR2023-00224, -00317

Nov 22, 2023EXHIBITPETITIONER

EX1115 EX2032 West Dec from IPR2023-00224, -00317

Nov 22, 2023EXHIBITPETITIONER

EX1116 POR from IPR2023-00224

Nov 22, 2023EXHIBITPETITIONER

EX1117 Dawson Supplementary Materials

Nov 22, 2023EXHIBITPETITIONER

EX1118 Saunders, Stelka-accurate somatic small variant calling

Nov 22, 2023EXHIBITPETITIONER

EX1119 Ex. F to First Amended Complaint (Case 2)

Nov 22, 2023EXHIBITPETITIONER

EX1120 Danovi, A sequencing revolution in cancer

Nov 22, 2023EXHIBITPETITIONER

EX1121 Foresight's Mtn to Consolidate Related Cases

Nov 22, 2023EXHIBITPETITIONER

EX1122 POPR from IPR2023-00224('694)

Nov 22, 2023EXHIBITPETITIONER

EX1123 POPR from IPR2023-00317('033)

Nov 22, 2023EXHIBITPETITIONER

EX1124 POR from IPR2023-00317('033)

Nov 22, 2023EXHIBITPETITIONER

EX1125 Fed. Reg. 24503

Nov 22, 2023EXHIBITPETITIONER

EX1126 [Redacted version] Personalis' Opposition to Mtn to Consolidate

Nov 22, 2023EXHIBITPETITIONER